Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency.
An 18-month-old girl presented with macrocytic megaloblastic anaemia followed by haemolytic uraemic syndrome. Metabolic investigations led to the identification of an inborn error of cobalamin metabolism consisting of defective methylcobalamin biosynthesis, probably cobalamin G, since methionine synthase activity was decreased under standard reducing conditions. Despite treatment, pulmonary hypertension progressively developed and responded to oxygen therapy. Renal involvement evolved to terminal failure and haemodialysis, while pulmonary hypertension was controlled by oxygen therapy. Such clinical manifestations have never been reported in association with a defect of methylcobalamin and thus of methionine biosynthesis. A congenital abnormality of cobalamin metabolism was suspected then confirmed in the presence of typical haematological features associated with unusual clinical manifestations such as progressive renal failure and pulmonary hypertension.
Labrune
P
P
Service de Pédiatrie, Hôpital Antoine Béclére, Clamart, France. philippe.labrune@abc.ap-hop-paris.fr
Zittoun
J
J
Duvaltier
I
I
Trioche
P
P
Marquet
J
J
Niaudet
P
P
Odièvre
M
M
D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000172:deficiency*; D000749:Anemia, Megaloblastic / Q000150:complications; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology*; D007223:Infant; D008661:Metabolism, Inborn Errors / Q000150:complications; D008715:Methionine / Q000378:metabolism; D014805:Vitamin B 12 / Q000378:metabolism*
D008715:Methionine; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; D014805:Vitamin B 12